Merck receives FDA approval for new formulation of Isentress What’s Next To

Merck receives FDA approval for new formulation of Isentress As we continue to ... This vaccine makes up about 15% -20% of the Merck anti-infectiv...


Merck receives FDA approval for new formulation of Isentress As we continue to
This vaccine makes up about 15% -20% of the Merck anti-infectives division revenues (reflected with Nasonex), which in turn represents about 23% to the value of the company, according to our estimates. This means that there can be 5% of the Merck-value …
Read more at NASDAQ

Leave a Reply